MOFgen Ltd

company

About

MOFgen Ltd for medical and therapeutic applications.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
£300K
Industries
Health Care,Manufacturing,Medical
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Close

MOFgen Ltd is an award winning VC-backed SME spin-out from the University of St Andrews and is the first company to commercialise MOFs for medical and therapeutic applications.

The company’s patented technology was pioneered in the laboratories of world renowned porous material scientist Prof Russell Morris FRS within the School of Chemistry at St Andrews.

With roots in the leading research group of its field, MOFgen is exploiting its strong IP and knowhow assets in the areas of MOF design, application, manufacturing and formulation to deliver cutting edge solutions to healthcare challenges. Through an ethos of innovation and collaboration, MOFgen works closely with its partners, to develop bespoke solutions to prevent healthcare associated infections, avoid bacterial resistance, heal chronic wounds and address arterial access.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£300K
MOFgen Ltd has raised a total of £300K in funding over 2 rounds. Their latest funding was raised on Dec 12, 2016 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2016 Seed £300K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
MOFgen Ltd is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Seed